brexit
Top Ten most popular articles on Pharmafile.com this week!
November 23, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kymriah, Mundipharma, UK, US, brexit, pharma, politics, top 10
The appointment of GSK veteran Arnaud Breabout to the position of Senior Vice President and CFO of Mundipharma took the …
MHRA Chief to step down in 2019
November 21, 2018Medical Communications, Research and Development MHRA, UK, brexit, pharma
The Medicines and Healthcare products Regulatory Agency (MHRA), the regulator responsible for the efficacy and safety of medicines in the …
Top Ten most popular articles on Pharmafile.com this week!
November 16, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Korea, NICE, Samsung, Theresa May, UK, brexit, politics, top 10
The Samsung scandal played a prominent role in this weeks’ top ten after the South Korean firm was delisted from …
Phamaceutical trade lobby responds to Brexit deal
November 15, 2018Business Services, Medical Communications, Research and Development ABPI, brexit, negotiations, pharma, politics
The Association of the British Pharmaceutical Industry (ABPI) has responded to Theresa May’s Brexit deal, after the government announced a …
No-deal Brexit preparations are a waste of time and money, according to Welsh industry representatives
November 12, 2018Sales and Marketing ABPI, brexit, no-deal, pharma, stockpiling
The UK government’s request that pharmaceutical companies stockpile an additional six weeks’ worth of medicine, in preparation for a no-deal …
The November 2018 issue of Pharmafocus is available to read online now!
November 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, President trump, Trump, anti vaxxer, brexit, clinical trials, opioid crisis, opioids, pharma, vaccines
As the US continues to battle the demons in its healthcare system, Donald Trump looks like he may finally make …
Top Ten most popular articles on Pharmafile.com this week!
October 26, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, GSK, HDA, J&J, JJ, brexit, clinical trials, pharmafile, resutls, stockpiling, top 10
Winter is coming! And with it an assortment of promising and not so promising results from big pharma. While J&J …
Industry leaders warn public may have to stockpile medicines in case of no-deal Brexit
October 24, 2018Research and Development brexit, no-deal Brexit, stockpiling
Martin Sawer, the executive director of the Healthcare Distribution Association (HDA) – formerly the British Association of Pharmaceutical Wholesalers (BAPW) …
Top Ten most popular articles on Pharmafile.com this week
October 19, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, AstraZeneca, Bayer, Novartis, Samsung, Trump, biosimilars, brexit
Business, biosimilars and Brexit are the themes of this week’s top 10. While Roche signed a $1 billion deal with …
AstraZeneca halting UK investment due to Brexit uncertainty
October 15, 2018Manufacturing and Production AstraZeneca, Le Monde, UK, brexit, no-deal
The Anglo-Swedish pharma firm AstraZeneca has suspended investment into the United Kingdom, due to the uncertainty surrounding Brexit. The firm’s …
MHRA to consult on potential for no-deal Brexit
October 5, 2018Medical Communications EU, MHRA, brexit, uk politics
The Medicines and Healthcare products Regulatory Agency (MHRA) has opened a consultation on how its legislation and regulatory processes would …
Survey reveals 56% gender pay gap between doctors in NHS
October 4, 2018Medical Communications NHS, UK, brexit, doctors, pay gap
Male doctors in the United Kingdom earn 56% more than their female counterparts, according to a survey conducted by Medscape. …
Clinical trial halted because of Brexit, UK Government downplays concerns
October 3, 2018Research and Development UK, brexit, clinical trials, politics, research
A clinical trial looking into the safety and efficacy of the drug dutogliptin has been halted due to uncertainties surrounding …
EMA says pharma industry now more prepared for Brexit
September 27, 2018Manufacturing and Production, Medical Communications EMA, EU, brexit, products, qppv
In July of this year the European Medicines Agency (EMA) identified significant gaps in the pharmaceutical industry’s preparedness for Brexit. …
Top Ten most popular articles on Pharmafile.com this week
September 14, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myers Squibb, FDA, NICE, Novo Nordisk, Spinraza, brexit, bristol myers squibb, top 10
With the Pharmafocus team having avoided hurricane Florence and finally arriving back in the UK just last night, after stopping …
Latest content
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
